OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 3.005
-0.100 (-3.22%)
Nov 3, 2026, 5:25 PM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 82.94 million as of November 3, 2026. It is the 42,317th most valuable company in the world and the 622nd biggest in Sweden. Its market cap has increased by 25.63% in one year.
Market Cap
82.94M
Enterprise Value
89.69M
Revenue
5.97M
Global Rank
Country Rank
#622 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has decreased from 89.02M to 82.94M, a decrease of -6.83%. That is a compound annual growth rate of -1.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 82.94M | -2.99% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abera Bioscience AB | 140.62M |
| Initiator Pharma | 135.88M |
| Xintela AB | 128.33M |
| Active Biotech AB | 106.76M |
| Alzinova AB | 103.51M |
| Biovica International AB | 98.67M |
| Ascelia Pharma AB | 71.98M |
| Pila Pharma AB | 71.95M |